Segesterone Acetate, Ethinyl Estradiol Ring
NDC Package 12822-0313-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Segesterone Acetate, Ethinyl Estradiol rings is a human prescription drug. This formulation utilizes a ring delivery system. Marketed by Sever Pharma Solutions Ab, this product is identified by NDC 12822-0313.

Identification & Billing

NDC Package Code
12822-0313-1
Package Description
1 POUCH in 1 CARTON / 1 RING in 1 POUCH
Product Code
12822-0313
11-Digit Billing Format
12822031301

Clinical Specifications

Proprietary Name
Segesterone Acetate, Ethinyl Estradiol
Non-Proprietary Name
Segesterone Acetate, Ethinyl Estradiol
Substance Name
Ethinyl Estradiol; Segesterone Acetate
Dosage Form
Ring - A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Sever Pharma Solutions Ab
Product Type
Human Prescription Drug
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
08-08-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 12822-0313-1 identifies a specific commercial package of 1 pouch in 1 carton / 1 ring in 1 pouch of Segesterone Acetate, Ethinyl Estradiol (UNFINISHED drug), a human prescription drug labeled by Sever Pharma Solutions Ab. This ring is formulated for use and contains ethinyl estradiol; segesterone acetate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sever Pharma Solutions Ab on August 08, 2019. The current certification is valid through December 31, 2026.

How is this Sever Pharma Solutions Ab product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 12822031301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
12822-0313-1
11-Digit CMS (5-4-2)
12822-0313-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.